These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30585027)

  • 1. [Evaluation of strain indexes and prognosis of patients with cardiac amyloidosis with preserved LVEF by three-dimensional speckle tracking imaging].
    Yu ZH; Wu BF; Zhou YJ; Yan H; Zhu JH
    Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3842-3847. PubMed ID: 30585027
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography.
    Baccouche H; Maunz M; Beck T; Gaa E; Banzhaf M; Knayer U; Fogarassy P; Beyer M
    Echocardiography; 2012 Jul; 29(6):668-77. PubMed ID: 22486396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial dysfunction in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy - A comparative three-dimensional speckle-tracking echocardiographic analysis from the MAGYAR-Path Study.
    Földeák D; Kormányos Á; Domsik P; Kalapos A; Piros GÁ; Ambrus N; Ajtay Z; Sepp R; Borbényi Z; Forster T; Nemes A
    Rev Port Cardiol; 2017 Dec; 36(12):905-913. PubMed ID: 29233648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy.
    Vitarelli A; Lai S; Petrucci MT; Gaudio C; Capotosto L; Mangieri E; Ricci S; Germanò G; De Sio S; Truscelli G; Vozella F; Pergolini MS; Giordano M
    Int J Cardiol; 2018 Nov; 271():371-377. PubMed ID: 30049493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic characteristics of PRKAG2 syndrome: a research using three-dimensional speckle tracking echocardiography compared with sarcomeric hypertrophic cardiomyopathy.
    Tang L; Li X; Zhou N; Jiang Y; Pan C; Shu X
    Cardiovasc Ultrasound; 2022 May; 20(1):14. PubMed ID: 35509080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional speckle tracking echocardiography allows detailed evaluation of left atrial function in hypertrophic cardiomyopathy--insights from the MAGYAR-Path Study.
    Domsik P; Kalapos A; Chadaide S; Sepp R; Hausinger P; Forster T; Nemes A
    Echocardiography; 2014 Nov; 31(10):1245-52. PubMed ID: 24649997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
    Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
    Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
    Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Left Ventricular Filling Pressure by 3-Dimensional Speckle-Tracking Echocardiography in Patients With Coronary Artery Disease.
    Ma H; Xie RA; Gao LJ; Zhang JP; Wu WC; Wang H
    J Ultrasound Med; 2015 Oct; 34(10):1809-18. PubMed ID: 26333567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of two-dimensional and speckle tracking echocardiography in "Gray Zone" left ventricular hypertrophy to differentiate professional football player's heart from hypertrophic cardiomyopathy.
    Kansal MM; Lester SJ; Surapaneni P; Sengupta PP; Appleton CP; Ommen SR; Ressler SW; Hurst RT
    Am J Cardiol; 2011 Nov; 108(9):1322-6. PubMed ID: 21855830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations].
    Zhao J; Wang J; Liu LW; Zheng Y; Wang B; Li WX; Yang F; Kang N; Zuo L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):287-293. PubMed ID: 32370479
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
    Zhang XM; Zhuang Q; Yang MH; Wang W; Zheng Y; Qiao ZQ; Shen JY; Shen XD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Dec; 46(12):965-971. PubMed ID: 30572401
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography.
    Luis SA; Yamada A; Khandheria BK; Speranza V; Benjamin A; Ischenko M; Platts DG; Hamilton-Craig CR; Haseler L; Burstow D; Chan J
    J Am Soc Echocardiogr; 2014 Mar; 27(3):285-91. PubMed ID: 24325960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
    Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
    Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Left Ventricular Myocardial Viability by 3-Dimensional Speckle-Tracking Echocardiography in Patients With Myocardial Infarction.
    Ran H; Zhang PY; Zhang YX; Zhang JX; Wu WF; Dong J; Ma XW
    J Ultrasound Med; 2016 Aug; 35(8):1631-8. PubMed ID: 27302895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Analysis of Myocardial Strain to Wall Thickness Ratio in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy.
    Gannon MP; Sison CP; Saba SG
    J Thorac Imaging; 2024 Jul; 39(4):255-264. PubMed ID: 38193208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters.
    Urbano-Moral JA; Gangadharamurthy D; Comenzo RL; Pandian NG; Patel AR
    Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):657-64. PubMed ID: 26092748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular three-dimensional global systolic strain by real-time three-dimensional speckle-tracking in children: feasibility, reproducibility, maturational changes, and normal ranges.
    Zhang L; Gao J; Xie M; Yin P; Liu W; Li Y; Klas B; Sun J; Balluz R; Ge S
    J Am Soc Echocardiogr; 2013 Aug; 26(8):853-9. PubMed ID: 23791113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.